1. Home
  2. HYFM vs ENLV Comparison

HYFM vs ENLV Comparison

Compare HYFM & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hydrofarm Holdings Group Inc.

HYFM

Hydrofarm Holdings Group Inc.

N/A

Current Price

$0.81

Market Cap

4.5M

Sector

Industrials

ML Signal

N/A

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

N/A

Current Price

$1.29

Market Cap

4.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HYFM
ENLV
Founded
1977
2005
Country
United States
Israel
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5M
4.0M
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
HYFM
ENLV
Price
$0.81
$1.29
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
251.7K
★ 1.6M
Earning Date
11-20-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $134,252,000.00
N/A
Revenue This Year
$54.93
N/A
Revenue Next Year
$5.31
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.50
$0.16
52 Week High
$3.20
$7.64

Technical Indicators

Market Signals
Indicator
HYFM
ENLV
Relative Strength Index (RSI) 50.12 54.08
Support Level $0.81 $0.84
Resistance Level $1.04 $2.89
Average True Range (ATR) 0.12 0.21
MACD 0.01 0.04
Stochastic Oscillator 57.89 40.66

Price Performance

Historical Comparison
HYFM
ENLV

About HYFM Hydrofarm Holdings Group Inc.

Hydrofarm Holdings Group Inc is an independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture (CEA), including grow lights, climate control solutions, grow media, nutrients, and other products. Hydroponics involves growing plants in soilless media, often using artificial lighting in controlled indoor or greenhouse environments. Its products are used to cultivate cannabis, flowers, fruits, vegetables, grains, and herbs, enabling control over key factors such as temperature, humidity, light, nutrients, and pH. Its product portfolio spans lighting, grow media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies. The United States generates maximum revenue.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.

Share on Social Networks: